Abstract

Nicotine, a nicotinic acetylcholine receptor agonist, produces the reinforcing effects of tobacco dependence by potentiating dopaminergic and glutamatergic neurotransmission. Non-nicotine alkaloids in tobacco also contribute to dependence by activating the cholinergic system. However, glutamatergic neurotransmission in the dorsal striatum associated with behavioral changes in response to cigarette smoking has not been investigated. In this study, the authors investigated alterations in glutamate levels in the rat dorsal striatum related to behavioral alterations after repeated administration of cigarette smoke condensate (CSC) using the real-time glutamate biosensing and an open-field behavioral assessment. Repeated administration of CSC including 0.4 mg nicotine (1.0 mL/kg/day, subcutaneous) for 14 days significantly increased extracellular glutamate concentrations more than repeated nicotine administration. In parallel with the hyperactivation of glutamate levels, repeated administration of CSC-evoked prolonged hypersensitization of psychomotor activity, including locomotor and rearing activities. These findings suggest that the CSC-induced psychomotor activities are closely associated with the elevation of glutamate concentrations in the rat dorsal striatum.

Highlights

  • Cigarette smoking is one of the greatest public health threats in the world

  • Non-nicotine alkaloids in tobacco that are structurally similar to nicotine, such as, nornicotine, cotinine, anabasine and anatabine, activate dopaminergic and glutamatergic neurotransmission by stimulating nicotinic acetylcholine receptors (nAChRs) in the terminals of neurons (Huang and Hsieh, 2007; Maciuk et al, 2008; Clemens et al, 2009; Hoffman and Evans, 2013)

  • The present study shows that repeated administration of cigarette smoke condensate (CSC) significantly increased extracellular glutamate concentrations in the rat dorsal striatum

Read more

Summary

Introduction

Cigarette smoking is one of the greatest public health threats in the world. It is estimated that about 28 billion people, which is more than 40% of the global population are affected by tobacco smoke (World Health Organization, 2015). Stimulation of dopaminergic projections increases dopamine release, which is followed by glutamate release, in brain regions, such as, the dorsal striatum, NAc and PFC. This release has been shown to be associated with drug dependence (Kalivas, 2004; Zhao-Shea et al, 2011; Li et al, 2014). Acetaldehyde, a constituent of tobacco, is biologically active and plays role in reinforcing properties of tobacco smoking (Talhout et al, 2007; Brancato et al, 2014) These findings suggest that upregulation of the cholinergic system by non-nicotine compounds plays a crucial role in tobacco dependence. The contribution made by these compounds to tobacco dependence is not well understood

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call